AstraZeneca India to halt equity trading before financial results release in late September Back

<p>AstraZeneca Pharma India Limited will close its trading window for equity shares from September 16, 2026, in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and the company’s Code of Conduct for Prevention of Insider Trading, with reopening scheduled after 48 hours from the declaration of unaudited financial results for the quarter and half year ending September 30, 2026.</p>